510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K770455Substantially Equivalent

Glucose Procedure, Tekpoint Direct

Icn Pharmaceuticals, Inc., Orangeburg NY / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K770455 is the FDA 510(k) clearance record for GLUCOSE PROCEDURE, TEKPOINT DIRECT, a class II device, cleared for Icn Pharmaceuticals, Inc. on under FDA product code CGE (Orthotoluidine, Glucose). FDA records list 30 510(k) clearances for Icn Pharmaceuticals, Inc., from to . As of , FDA records show no recalls naming K770455.

Clearance record

Decision date
Received
(56 days to decision)
Product code
CGE Orthotoluidine, Glucose
Regulation
21 CFR 862.1345
Device class
Class II
Review panel
Clinical Chemistry
Applicant
Icn Pharmaceuticals, Inc. 13 Mountainview Ave., Orangeburg NY
Third party review
No

Clearances, product code CGE

Trailing 12 months

FDA records hold no clearances under product code CGE in the trailing twelve months.

FDA records show no clearances under product code CGE in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code CGE, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260